US Patent 11905309 Neuroactive steroids and methods of use thereof
Patent 11905309 was granted and assigned to SAGE Therapeutics on February, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+30 properties)
Article (+233 characters)
US Patent 11905309 Neuroactive steroids and methods of use thereof
Article
Patent abstract
3beta, 17beta disubstituted steroidal compounds, pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, are provided for the prevention and treatment of a variety of CNS-related conditions.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Albert Jean Robichaud0
Boyd L Harrison0
Francesco G. Salituro0
Gabriel Martinez Botella0
Date of Patent
February 20, 2024
0Patent Application Number
173818290
Date Filed
July 21, 2021
0Patent Citations
Patent Primary Examiner
CPC Code
Find more entities like US Patent 11905309 Neuroactive steroids and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.